Loading...
NeuBase Therapeutics, Inc.
NBSE•NASDAQ
HealthcareBiotechnology
$0.38
$-0.01(-1.56%)
NeuBase Therapeutics, Inc. (NBSE) Quarterly Earnings Reports & Financial Results
Analyze NeuBase Therapeutics, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of NeuBase Therapeutics, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
NeuBase Therapeutics, Inc. (NBSE) Quarterly Earnings Details
Detailed breakdown of NeuBase Therapeutics, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.